New drug NTR-1011 tested for safety in lupus and arthritis patients
NCT ID NCT07237659
First seen Nov 20, 2025 · Last updated May 17, 2026 · Updated 25 times
Summary
This early-stage study tested the safety of a new drug called NTR-1011 in 36 healthy adults and people with lupus or rheumatoid arthritis. The goal was to find a safe dose and see how the drug behaves in the body. The study was completed, but it is too early to know if the drug works for these conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SLE (SYSTEMIC LUPUS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
California Clinical Trials Medical Group
Glendale, California, 91206, United States
Conditions
Explore the condition pages connected to this study.